{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:41:41Z","timestamp":1775230901024,"version":"3.50.1"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1097\/ico.0b013e318207fc42","type":"journal-article","created":{"date-parts":[[2011,10,5]],"date-time":"2011-10-05T00:10:37Z","timestamp":1317773437000},"page":"1145-1149","source":"Crossref","is-referenced-by-count":56,"title":["Oral Azithromycin for Treatment of Posterior Blepharitis"],"prefix":"10.1097","volume":"30","author":[{"given":"Thais Zamudio","family":"Igami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Holzchuh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tammy Hentona","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth Miyuki","family":"Santo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Newton","family":"Kara-Jose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard Y","family":"Hida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-14-20210204","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1542-0124(12)70086-1","article-title":"Eye: report of the Research Subcommittee of the International Dry Eye WorkShop (2007).","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"R2-14-20210204","first-page":"109","article-title":"Dry eye, blepharitis and chronic eye irritation: divide and conquer.","volume":"18","author":"Gilbard","year":"1999","journal-title":"J Ophthalmic Nurs Technol"},{"key":"R3-14-20210204","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3129\/i08-016","article-title":"Blepharitis: current strategies for diagnosis and management.","volume":"43","author":"Jackson","year":"2008","journal-title":"Can J Ophthalmol"},{"key":"R4-14-20210204","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1542-0124(12)70620-1","article-title":"Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment.","volume":"7","author":"Lemp","year":"2009","journal-title":"Ocul Surf"},{"key":"R5-14-20210204","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0161-6420(82)34669-2","article-title":"Classification of chronic blepharitis.","volume":"89","author":"McCulley","year":"1982","journal-title":"Ophthalmology"},{"key":"R6-14-20210204","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/00003226-200009000-00010","article-title":"Changing concepts in the diagnosis and management of blepharitis.","volume":"19","author":"McCulley","year":"2000","journal-title":"Cornea"},{"key":"R7-14-20210204","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0039-6257(96)80064-6","article-title":"Meibomian gland dysfunction.","volume":"40","author":"Driver","year":"1996","journal-title":"Surv Ophthalmol"},{"key":"R8-14-20210204","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/archopht.1995.01100100054027","article-title":"Ocular surface changes and discomfort in patients with meibomian gland dysfunction.","volume":"113","author":"Shimazaki","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"R9-14-20210204","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.exer.2007.02.003","article-title":"Exposure to a dry environment induces strain-specific responses in mice.","volume":"84","author":"Barabino","year":"2007","journal-title":"Exp Eye Res"},{"key":"R10-14-20210204","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0668.2006.00441.x","article-title":"Changes of symptoms, tear film stability and eosinophilic cationic protein in nasal lavage fluid after re-exposure to a damp office building with a history of flooding.","volume":"17","author":"Wieslander","year":"2007","journal-title":"Indoor Air"},{"issue":"Suppl 2","key":"R12-14-20210204","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1016\/S0039-6257(00)00202-2","article-title":"Dry eye disease: the scale of the problem.","volume":"45","author":"Brewitt","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"R13-14-20210204","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/ICO.0b013e31812f6913","article-title":"Concept of functional visual acuity and its applications.","volume":"26","author":"Kaido","year":"2007","journal-title":"Cornea"},{"key":"R14-14-20210204","first-page":"11","article-title":"Evaluation and differential diagnosis of keratoconjunctivitis sicca.","volume":"61","author":"Lemp","year":"2000","journal-title":"J Rheumatol Suppl"},{"key":"R15-14-20210204","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00003226-199907000-00003","article-title":"Results of a population-based questionnaire on the symptoms and lifestyles associated with dry eye.","volume":"18","author":"Shimmura","year":"1999","journal-title":"Cornea"},{"key":"R16-14-20210204","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/09546630701881506","article-title":"Azithromycin pulses in the treatment of inflammatory and pustular acne: efficacy, tolerability and safety.","volume":"19","author":"Antonio","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"R17-14-20210204","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2230.2006.02322.x","article-title":"The effect of azithromycin on reactive oxygen species in rosacea.","volume":"32","author":"Bakar","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"R18-14-20210204","first-page":"274","article-title":"Comparison of oral azithromycin pulse with daily doxycycline in the treatment of acne vulgaris.","volume":"69","author":"Singhi","year":"2003","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R19-14-20210204","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-4632.2008.03445.x","article-title":"Comparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: a randomized open clinical trial.","volume":"47","author":"Akhyani","year":"2008","journal-title":"Int J Dermatol"},{"key":"R20-14-20210204","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-4632.2004.01958.x","article-title":"Therapeutic potential of azithromycin in rosacea.","volume":"43","author":"Bakar","year":"2004","journal-title":"Int J Dermatol"},{"key":"R21-14-20210204","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1468-3083.2009.03132.x","article-title":"Ocular signs, symptoms and tear function tests of papulopustular rosacea patients receiving azithromycin.","volume":"23","author":"Bakar","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R22-14-20210204","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/archderm.140.4.489","article-title":"Oral use of azithromycin for the treatment of acne rosacea.","volume":"140","author":"Fernandez-Obregon","year":"2004","journal-title":"Arch Dermatol"},{"key":"R23-14-20210204","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-4362.1997.tb04199.x","article-title":"Azithromycin for the treatment of acne.","volume":"36","author":"Fernandez-Obregon","year":"1997","journal-title":"Int J Dermatol"},{"key":"R24-14-20210204","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-4362.2000.00749.x","article-title":"Azithromycin for the treatment of acne.","volume":"39","author":"Fernandez-Obregon","year":"2000","journal-title":"Int J Dermatol"},{"issue":"Suppl B","key":"R25-14-20210204","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/41.suppl_2.37","article-title":"Anti-inflammatory activity of macrolides: a new therapeutic potential?","volume":"41","author":"Labro","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"R26-14-20210204","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1468-3083.2008.02609.x","article-title":"Rosacea\/acne rosacea: efficacy of combination therapy of azithromycin and topical 0.1% tacrolimus ointment.","volume":"22","author":"Sehgal","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R27-14-20210204","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/ICO.0b013e3181cda38f","article-title":"Topical azithromycin therapy for meibomian gland dysfunction: clinical response and lipid alterations.","volume":"29","author":"Foulks","year":"2010","journal-title":"Cornea"},{"key":"R28-14-20210204","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/ICO.0b013e3181ca38a0","article-title":"Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis.","volume":"29","author":"Haque","year":"2010","journal-title":"Cornea"},{"key":"R29-14-20210204","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s12325-008-0096-9","article-title":"Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis.","volume":"25","author":"Luchs","year":"2008","journal-title":"Adv Ther"},{"key":"R30-14-20210204","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00003226-199307000-00015","article-title":"Practical double vital staining for ocular surface evaluation.","volume":"12","author":"Toda","year":"1993","journal-title":"Cornea"},{"key":"R31-14-20210204","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/BF00404705","article-title":"Prevalence of dry eye in Japanese eye centers.","volume":"233","author":"Hikichi","year":"1995","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R32-14-20210204","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/bjo.83.7.767","article-title":"New treatment of dry eye: the effect of calcium ointment through eyelid skin delivery.","volume":"83","author":"Tsubota","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"R33-14-20210204","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ophtha.2003.09.034","article-title":"Punctal occlusion in the management of chronic Stevens-Johnson syndrome.","volume":"111","author":"Kaido","year":"2004","journal-title":"Ophthalmology"},{"key":"R34-14-20210204","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1001\/archopht.1969.00990020012003","article-title":"Diagnostic tests in the sicca syndrome.","volume":"82","author":"van Bijsterveld","year":"1969","journal-title":"Arch Ophthalmol"},{"key":"R35-14-20210204","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijantimicag.2007.08.001","article-title":"Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators.","volume":"31","author":"Giamarellos-Bourboulis","year":"2008","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 9A","key":"R36-14-20210204","first-page":"2S","article-title":"Immunomodulatory properties of macrolides: overview and historical perspective.","volume":"117","author":"Rubin","year":"2004","journal-title":"Am J Med"},{"key":"R37-14-20210204","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1345\/aph.1E282","article-title":"Use of macrolides and tetracyclines for chronic inflammatory diseases.","volume":"39","author":"Voils","year":"2005","journal-title":"Ann Pharmacother"},{"key":"R38-14-20210204","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/bjo.2006.091579","article-title":"Short term oral minocycline treatment of meibomianitis.","volume":"90","author":"Aronowicz","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R39-14-20210204","first-page":"2970","article-title":"The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci.","volume":"32","author":"Dougherty","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R40-14-20210204","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0014-4835(03)00005-8","article-title":"Minocycline effect on meibomian gland lipids in meibomianitis patients.","volume":"76","author":"Shine","year":"2003","journal-title":"Exp Eye Res"},{"key":"R41-14-20210204","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00003226-200308000-00011","article-title":"Effects of minocycline on the ocular flora of patients with acne rosacea or seborrheic blepharitis.","volume":"22","author":"Ta","year":"2003","journal-title":"Cornea"},{"key":"R42-14-20210204","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4065\/74.6.613","article-title":"The macrolides: erythromycin, clarithromycin, and azithromycin.","volume":"74","author":"Alvarez-Elcoro","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"R44-14-20210204","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0022-3565(24)35272-3","article-title":"Anti-inflammatory activity of macrolide antibiotics.","volume":"292","author":"Ianaro","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"R45-14-20210204","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1023\/A:1022340107017","article-title":"Azithromycin impact on neutrophil oxidative metabolism depends on exposure time.","volume":"22","author":"Levert","year":"1998","journal-title":"Inflammation"},{"key":"R46-14-20210204","first-page":"1625","article-title":"KF, al-Kharashi SA, al-Mansouri SM, et al. Ocular levels of azithromycin.","volume":"116","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"R47-14-20210204","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/bjo.68.8.524","article-title":"Comparative bacteriology of chronic blepharitis.","volume":"68","author":"Dougherty","year":"1984","journal-title":"Br J Ophthalmol"},{"key":"R48-14-20210204","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00003226-199110010-00010","article-title":"Lid flora in blepharitis.","volume":"10","author":"Groden","year":"1991","journal-title":"Cornea"},{"key":"R49-14-20210204","first-page":"1932","article-title":"The role of wax and sterol ester fatty acids in chronic blepharitis.","volume":"32","author":"Dougherty","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R50-14-20210204","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/bjo.2007.133900","article-title":"Changes in meibomian fatty acids and clinical signs in patients with meibomian gland dysfunction after minocycline treatment.","volume":"92","author":"Souchier","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R51-14-20210204","first-page":"898","article-title":"Azithromycin as an alternative rosacea therapy when tetracyclines prove problematic.","volume":"7","author":"Modi","year":"2008","journal-title":"J Drugs Dermatol"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00003226-201110000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T12:45:43Z","timestamp":1741783543000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201110000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e318207fc42","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}